Cargando…

Retrospective Analysis of Gabapentin for Alcohol Withdrawal in the Hospital Setting: The Mayo Clinic Experience

OBJECTIVE: To evaluate the efficacy and safety of a fixed-dose gabapentin taper protocol for alcohol withdrawal in hospitalized patients. PATIENTS AND METHODS: We retrospectively identified patients admitted to the hospital from January 1, 2016, to April 30, 2018, for alcohol withdrawal syndrome. Ba...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bates, Ruth E., Leung, Jonathan G., Morgan, Robert J., Fischer, Karen M., Philbrick, Kemuel L., Kung, Simon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560568/ https://www.ncbi.nlm.nih.gov/pubmed/33083703 http://dx.doi.org/10.1016/j.mayocpiqo.2020.06.002

Ejemplares similares

Alcohol withdrawal-related outcomes associated with gabapentin use in an inpatient psychiatric facility
por: Nichols, Taylor A., et al.
Publicado: (2019)

Assessing Naltrexone Prescribing and Barriers to Initiation for Alcohol Use Disorder: A Multidisciplinary, Multisite Survey
por: Leung, Jonathan G., et al.
Publicado: (2022)

Effect of pretreatment with gabapentin on withdrawal movement associated with intravenous rocuronium injection
por: Yoon, Jin Sun, et al.
Publicado: (2011)

Castellano-mayo, mayo-castellano
por: Collard, Howard
Publicado: (1962)

Mayo Clinic Scottsdale Experience With Laparoscopic Nephroureterectomy
por: Simon, Scott D., et al.
Publicado: (2004)

Psychiatry’s role in the prevention of post-intensive care mental health impairment: stakeholder survey
por: Bieber, Ewa D., et al.
Publicado: (2022)

Gabapentin-Induced Priapism
por: Kashfi, Simon, et al.
Publicado: (2022)

Rationale for setting up a cardio-oncology unit: our experience at Mayo Clinic
por: Barros-Gomes, Sergio, et al.
Publicado: (2016)

LORAZEPAM FOR ALCOHOL WITHDRAWAL
por: Andrade, Chittaranjan
Publicado: (2003)

Treatment of Alcohol Withdrawal
por: Myrick, Hugh, et al.
Publicado: (1998)

Kindling in Alcohol Withdrawal
por: Becker, Howard C.
Publicado: (1998)

Introduction to Alcohol Withdrawal
por: Saitz, Richard
Publicado: (1998)

Gabapentin Effect on Pain Associated with Heroin Withdrawal in Iranian Crack: a Randomized Double-blind Clinical Trial
por: Behnam, Behnaz, et al.
Publicado: (2012)

Gabapentin for Post-Hospitalization Alcohol Relapse Prevention; Should Gabapentin Be Considered for FDA Approval in the Treatment of Alcohol Use Disorder?: A Case Presentation and Literature Review
por: Rutkofsky, Ian H, et al.
Publicado: (2020)

Treatment of Generalized Anxiety Disorder with Gabapentin
por: Markota, Matej, et al.
Publicado: (2017)

Collected Papers of the Mayo Clinic and the Mayo Foundation
Publicado: (1926)

Collected Papers of the Mayo Clinic and the Mayo Foundation
Publicado: (1927)

Sketch of the History of the Mayo Clinic and the Mayo Foundation. From the Division of Publications. Mayo Clinic
Publicado: (1928)

Gabapentin in Burns
por: Sheppard, Nicholas
Publicado: (2014)

Alcohol Dependence, Withdrawal, and Relapse
por: Becker, Howard C.
Publicado: (2008)

Animal Models of Alcohol Withdrawal
por: Becker, Howard C.
Publicado: (2000)

Exploring Alcohol Withdrawal Syndrome
por: Finn, Deborah A., et al.
Publicado: (1997)

Alcohol Withdrawal with Delirium Tremens
por: Schwebach, Courtney, et al.
Publicado: (2023)

Management of acute alcohol withdrawal in the setting of a quick diagnostic unit integrated in an emergency department setting
por: Bøhm, Pernille Würtz, et al.
Publicado: (2013)

Mayo clinic
por: Adenwalla, H.S.
Publicado: (2015)

Evolution of Metabolic Abnormalities in Alcoholic Patients during Withdrawal
por: Vandemergel, X., et al.
Publicado: (2015)

Collected Papers of the Mayo Clinic and the Mayo Foundation. Vol. XV
Publicado: (1925)

Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience
por: Vaxman, I., et al.
Publicado: (2023)

Gabapentin Enacarbil: Pharmacotherapy of Restless Legs Syndrome
por: Jones, Ruth, et al.
Publicado: (2010)

Gabapentin-induced Facial Myoclonus in the Setting of Acute on Chronic Kidney Disease
por: Hampton, Zach, et al.
Publicado: (2019)

Oxidative Stress During Alcohol Withdrawal and its Relationship with Withdrawal Severity
por: Parthasarathy, Ramamourty, et al.
Publicado: (2015)

Busulfan for the treatment of myeloproliferative neoplasms: the Mayo Clinic experience
por: Begna, K, et al.
Publicado: (2016)

Thyroidectomy for Amiodarone-Induced Thyrotoxicosis: Mayo Clinic Experience
por: Kotwal, Anupam, et al.
Publicado: (2018)

Telestroke in the Time of COVID-19: The Mayo Clinic Experience
por: Huang, Josephine F., et al.
Publicado: (2020)

The pharmacokinetics of gabapentin in cats
por: Adrian, Derek, et al.
Publicado: (2018)

Gabapentin—Friend or foe?
por: Russo, Marc, et al.
Publicado: (2022)

Potential role of gabapentin and extended-release gabapentin in the management of menopausal hot flashes
por: Yadav, Manisha, et al.
Publicado: (2013)

Catatonia in mixed alcohol and benzodiazepine withdrawal
por: Basu, Aniruddha, et al.
Publicado: (2014)

Baclofen versus lorazepam for alcohol withdrawal
por: Garag, Sagar S., et al.
Publicado: (2019)

Neurochemical Mechanisms Underlying Alcohol Withdrawal
por: Littleton, John
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_9c0unfo6g2vkvor2r49u7ucvj4